Cargando...
P08.55 δ-catenin modulates bevacizumab-induced glioma invasion
Introduction: Data showing that bevacizumab in combination with temozolomide and radiotherapy improved progression-free survival in patients with newly diagnosed glioblastoma have highlighted the potential of bevacizumab as a glioma therapy. However, while bevacizumab potently suppresses angiogenesi...
Gardado en:
| Publicado en: | Neuro Oncol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Oxford University Press
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5464067/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox036.244 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|